RSS Search

 News  Feeds  Images  Tags  Search Shortcuts

Feedsfarm.com > Feeds > bizjournals.com Health Care:Pharmaceuticals headlines > Archive

bizjournals.com Health Care:Pharmaceuticals headlines News Archive

Health Care:Pharmaceuticals headlines from the week of November 13, 2006

http://www.bizjournals.com/rss/feed/?t=vertical_subtopic&id=36

Page: 1 of 10 bizjournals.com Health Care:Pharmaceuticals headlines

  1. Back to its core, aaiPharma growing in Morrisville
  2. Drug benefit firm scores
  3. Reversal of fortune: Drug results drive Vertex growth
  4. Gilead cuts HIV drug prices in poorest nations
  5. Life science firms bringing tax windfall to U.S.
  6. Vioxx verdict could cause local tremors
  7. Locals respond with hurricane relief efforts
  8. PDL makes strides in treating heart failure
  9. Voyager files for IPO, aims for $129M
  10. A&G raises $2M to test cancer screening products
  11. Investors feeling fussy as Martek reports 3Q loss
  12. Senior executive to leave Advancis
  13. Lipid sees success in monkey virus trials
  14. Cargill to buy Degussa unit for $670M
  15. Geron plans stock offering, Merck buying $18M in shares
  16. Emory administrator joins UAB as dean of graduate school
  17. Edwards board OKs stock buyback
  18. Alkermes gets nod to market schizophrenia drug in Italy
  19. AIDS groups raise money for hurricane victims
  20. Glaxo to pay $150M to settle fraudulent pricing case
  21. Encore hits 25M mark
  22. Spherix sweetener nears European approval
  23. Pennsylvania pharmaceutical company extends contract with DPT
  24. LabCorp launches genomic testing
  25. Wake Forest names new director for research park
  26. VaxGen will sell part of Korean company
  27. Kendle official to oversee expansion efforts
  28. Medtronic names new neurologics chief
  29. UC to study diseases that blind
  30. Merck starts mag
  31. FDA extends review of drug by Cephalon, partner
  32. Northeastern wins $3.3 Cancer Institute grant
  33. Praecis Pharma reports promising early data on lymphoma drug
  34. UTEK's latest alliance focuses on life science technologies
  35. Myogen completes offering
  36. SLU, Siga to develop smallpox drug
  37. GSK, Roche to test osteoporosis drug
  38. Genzyme test identifies patients for lung-cancer therapies
  39. Sunesis stock falls 7 percent in IPO
  40. Stanford gets $6.25M lymphoma grant
  41. Hepatitis warning issued for gaming expo attendees
  42. Tempe student's diabetic testing the focus of lawsuit
  43. Medtronic receives FDA approval for bone growth protein
  44. Hopkins to study how stem cells could help hearts
  45. Hopkins scientist lands $2.5M to study viruses
  46. Target to sell pink products to support breast cancer research
  47. Survey: Minnesota seniors slow to join new Medicare drug plan
  48. Glaxo to market Allergan's Botox in Japan, China
  49. Australian drug firm to pay $104M for Control Delivery Systems
  50. PolyMedica sells women's health unit to Amerifit for $45M
  51. Emory, Georgia Tech named 'National Centers of Cancer Nanotechnology Excellence'
  52. Local biotech raises $8.5M
  53. MGI Pharma completes Guilford deal
  54. Dynavax Technologies to sell 4M shares
  55. Codexis reaches second Pfizer deal milestone
  56. Benitec drops patent suit against Nucleonics
  57. CU researcher receives Nobel Prize
  58. UMass-Amherst microbiologist lands $21.8M research grant
  59. Express Scripts to push generic prescriptions next year
  60. UT receives $3.5M for drug development
  61. Endo shareholder's stock on the block
  62. State Street German unit to manage funds for French pension
  63. UNC to participate in $144.3M cancer nanotechnology initiative
  64. EntreMed's arthritis drug shows promise
  65. Chicago fund to buy $20M of Ceptor stock
  66. Hutchinson cancer center gets $18M grant
  67. GenVec HIV vaccine reaches Phase II
  68. FDA to review drug; GSK to pay Pozen $20M
  69. Court halts Big Isle algae project
  70. Surface Logix completes first human trial for new drug
  71. ResCare calls remaining senior notes for redemption
  72. Guidant reports more device failures
  73. Nastech developing nasal insulin formula
  74. Advanced Neuromodulation being sold in $1.3B deal
  75. Local biotech firm gets order from Lehigh University
  76. Sona MedSpa opens Greensboro location
  77. Altus Pharmaceuticals files for IPO
  78. GenVec looks to sell cell-therapy program
  79. Uroplasty shares soar on device approval
  80. Genentech inks another brain cancer deal
  81. State would borrow $1B for Stem Cell Institute under Paterson plan
  82. Alinea Pharmaceuticals lands $45M first round
  83. Broussard named president of US Oncology
  84. Discovery Labs resubmits drug candidate
  85. UMass opens Biologic Laboratories expansion
  86. CareStat acquired by Ohio trust
  87. Idenix Pharmaceuticals to sell 6.6M shares
  88. BioCryst Pharmaceuticals' Q3 revenue hit by NIH grant reduction
  89. Sapiens' boss stepping down; new CEO named
  90. Charles River plans lab closing to cut costs
  91. Nabi plunges on failed staph vaccine
  92. SAFC Biosciences inks agreement with ProBioGen
  93. 'Compounding' pharmacy opens
  94. FDA approves Genentech drug in combo use
  95. Advancis ready for another Phase III trial
  96. Sirna loss drops
  97. Merck wins in second Vioxx trial
  98. Revenue up, net loss down at GenVec
  99. Merck prevails in case against Vioxx
  100. St. Jude gets gov't OK to buy Advanced Neuromodulation